Adoptive transfer of siRNA Cblb-silenced CD8+ T lymphocytes augments tumor vaccine efficacy in a B16 melanoma model.
The ubiquitin ligase Cbl-b is an established regulator of T cell immune response thresholds. We recently showed that adoptive cell transfer (ACT) of cblb(-/-) CD8(+) T cells enhances dendritic cell (DC) immunization-mediated anti-tumor effects in immune-competent recipients. However, translation of...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0044295&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850137091664510976 |
|---|---|
| author | Reinhard Hinterleitner Thomas Gruber Christa Pfeifhofer-Obermair Christina Lutz-Nicoladoni Alexander Tzankov Manfred Schuster Josef M Penninger Hans Loibner Günther Lametschwandtner Dominik Wolf Gottfried Baier |
| author_facet | Reinhard Hinterleitner Thomas Gruber Christa Pfeifhofer-Obermair Christina Lutz-Nicoladoni Alexander Tzankov Manfred Schuster Josef M Penninger Hans Loibner Günther Lametschwandtner Dominik Wolf Gottfried Baier |
| author_sort | Reinhard Hinterleitner |
| collection | DOAJ |
| description | The ubiquitin ligase Cbl-b is an established regulator of T cell immune response thresholds. We recently showed that adoptive cell transfer (ACT) of cblb(-/-) CD8(+) T cells enhances dendritic cell (DC) immunization-mediated anti-tumor effects in immune-competent recipients. However, translation of cblb targeting to clinically applicable concepts requires that inhibition of cblb activity be transient and reversible. Here we provide experimental evidence that inhibition of cblb using chemically synthesized siRNA has such potential. Silencing cblb expression by ex vivo siRNA transfection of polyclonal CD8(+) T cells prior to ACT increased T cell tumor infiltration, significantly delayed tumor outgrowth, and increased survival rates of tumor-bearing mice. As shown by ex vivo recall assays, cblb silencing resulted in significant augmentation of intratumoral T cell cytokine response. ACT of cblb-silenced polyclonal CD8(+) T cells combined with DC-based tumor vaccines predominantly mediated anti-tumor immune responses, whereas no signs of autoimmunity could be detected. Importantly, CBLB silencing in human CD8(+) T cells mirrored the effects observed for cblb-silenced and cblb-deficient murine T cells. Our data validate the concept of enhanced anti-tumor immunity by repetitive ACT of ex vivo cblb siRNA-silenced hyper-reactive CD8(+) T cells as add-on adjuvant therapy to augment the efficacy of existing cancer immunotherapy regimens in clinical practice. |
| format | Article |
| id | doaj-art-c1fde60581bd4e098550a7f3ce7af6b8 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2012-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-c1fde60581bd4e098550a7f3ce7af6b82025-08-20T02:30:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0179e4429510.1371/journal.pone.0044295Adoptive transfer of siRNA Cblb-silenced CD8+ T lymphocytes augments tumor vaccine efficacy in a B16 melanoma model.Reinhard HinterleitnerThomas GruberChrista Pfeifhofer-ObermairChristina Lutz-NicoladoniAlexander TzankovManfred SchusterJosef M PenningerHans LoibnerGünther LametschwandtnerDominik WolfGottfried BaierThe ubiquitin ligase Cbl-b is an established regulator of T cell immune response thresholds. We recently showed that adoptive cell transfer (ACT) of cblb(-/-) CD8(+) T cells enhances dendritic cell (DC) immunization-mediated anti-tumor effects in immune-competent recipients. However, translation of cblb targeting to clinically applicable concepts requires that inhibition of cblb activity be transient and reversible. Here we provide experimental evidence that inhibition of cblb using chemically synthesized siRNA has such potential. Silencing cblb expression by ex vivo siRNA transfection of polyclonal CD8(+) T cells prior to ACT increased T cell tumor infiltration, significantly delayed tumor outgrowth, and increased survival rates of tumor-bearing mice. As shown by ex vivo recall assays, cblb silencing resulted in significant augmentation of intratumoral T cell cytokine response. ACT of cblb-silenced polyclonal CD8(+) T cells combined with DC-based tumor vaccines predominantly mediated anti-tumor immune responses, whereas no signs of autoimmunity could be detected. Importantly, CBLB silencing in human CD8(+) T cells mirrored the effects observed for cblb-silenced and cblb-deficient murine T cells. Our data validate the concept of enhanced anti-tumor immunity by repetitive ACT of ex vivo cblb siRNA-silenced hyper-reactive CD8(+) T cells as add-on adjuvant therapy to augment the efficacy of existing cancer immunotherapy regimens in clinical practice.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0044295&type=printable |
| spellingShingle | Reinhard Hinterleitner Thomas Gruber Christa Pfeifhofer-Obermair Christina Lutz-Nicoladoni Alexander Tzankov Manfred Schuster Josef M Penninger Hans Loibner Günther Lametschwandtner Dominik Wolf Gottfried Baier Adoptive transfer of siRNA Cblb-silenced CD8+ T lymphocytes augments tumor vaccine efficacy in a B16 melanoma model. PLoS ONE |
| title | Adoptive transfer of siRNA Cblb-silenced CD8+ T lymphocytes augments tumor vaccine efficacy in a B16 melanoma model. |
| title_full | Adoptive transfer of siRNA Cblb-silenced CD8+ T lymphocytes augments tumor vaccine efficacy in a B16 melanoma model. |
| title_fullStr | Adoptive transfer of siRNA Cblb-silenced CD8+ T lymphocytes augments tumor vaccine efficacy in a B16 melanoma model. |
| title_full_unstemmed | Adoptive transfer of siRNA Cblb-silenced CD8+ T lymphocytes augments tumor vaccine efficacy in a B16 melanoma model. |
| title_short | Adoptive transfer of siRNA Cblb-silenced CD8+ T lymphocytes augments tumor vaccine efficacy in a B16 melanoma model. |
| title_sort | adoptive transfer of sirna cblb silenced cd8 t lymphocytes augments tumor vaccine efficacy in a b16 melanoma model |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0044295&type=printable |
| work_keys_str_mv | AT reinhardhinterleitner adoptivetransferofsirnacblbsilencedcd8tlymphocytesaugmentstumorvaccineefficacyinab16melanomamodel AT thomasgruber adoptivetransferofsirnacblbsilencedcd8tlymphocytesaugmentstumorvaccineefficacyinab16melanomamodel AT christapfeifhoferobermair adoptivetransferofsirnacblbsilencedcd8tlymphocytesaugmentstumorvaccineefficacyinab16melanomamodel AT christinalutznicoladoni adoptivetransferofsirnacblbsilencedcd8tlymphocytesaugmentstumorvaccineefficacyinab16melanomamodel AT alexandertzankov adoptivetransferofsirnacblbsilencedcd8tlymphocytesaugmentstumorvaccineefficacyinab16melanomamodel AT manfredschuster adoptivetransferofsirnacblbsilencedcd8tlymphocytesaugmentstumorvaccineefficacyinab16melanomamodel AT josefmpenninger adoptivetransferofsirnacblbsilencedcd8tlymphocytesaugmentstumorvaccineefficacyinab16melanomamodel AT hansloibner adoptivetransferofsirnacblbsilencedcd8tlymphocytesaugmentstumorvaccineefficacyinab16melanomamodel AT guntherlametschwandtner adoptivetransferofsirnacblbsilencedcd8tlymphocytesaugmentstumorvaccineefficacyinab16melanomamodel AT dominikwolf adoptivetransferofsirnacblbsilencedcd8tlymphocytesaugmentstumorvaccineefficacyinab16melanomamodel AT gottfriedbaier adoptivetransferofsirnacblbsilencedcd8tlymphocytesaugmentstumorvaccineefficacyinab16melanomamodel |